What Is a Turnkey Manufacturing Solution? And Is It Right for Your Company?
Managing multiple manufacturing vendors means managing multiple points of failure. One supplier for injection molding. Another for sub-assembly. A third for packaging. A fourth for compliance documentation. At every handoff, there's an opportunity for delays, quality gaps, and miscommunication.
There's a better way to structure it.
A turnkey manufacturing solution consolidates the entire production process under one partner, one quality system, and one point of accountability, from raw materials to shelf-ready product. For medical device and life sciences companies, that's not just an operational convenience. It's a strategic shift.
The Hidden Costs of Offshore Manufacturing (And Why Nearshore Is Changing the Math)
Unit cost is the number that wins budget meetings. It's clean, it's comparable, and for years, it made offshore manufacturing in Asia look like an easy call.
But for medical device and pharma companies, the true cost of offshore manufacturing has a way of hiding—right up until something goes wrong. A delayed shipment. A failed audit. A recalled lot. By then, the savings on that original spreadsheet are long gone.
Total cost of ownership changes the conversation. When you account for logistics volatility, excess inventory carrying costs, tariffs, quality oversight travel, and the compounding risk of a 30-day supply chain, the offshore unit cost advantage doesn't just shrink—it often disappears entirely. In regulated industries where compliance failures are catastrophic and supply disruptions carry patient safety implications, the math has quietly tilted toward nearshore.
This post breaks down the full TCO framework: seven hidden cost categories that offshore quotes never show you, a side-by-side numerical comparison, and what it looks like when those factors are built into a real sourcing decision.
Marie O’Malley to Speak on Manufacturing Tradeoffs Panel at MPP West 2026
PiSA USA’s Chief Commercial Officer, Marie O’Malley, will take the stage at MPP West 2026 to discuss one of MedTech’s biggest challenges—balancing cost, speed, and compliance. Joining industry leaders, she’ll share real-world insights on navigating manufacturing tradeoffs and scaling efficiently in today’s complex regulatory landscape.
From Pilot to Scale-Up: Navigating the Transition to Commercial Manufacturing with a CMO Partner
Transitioning from pilot to commercial manufacturing is one of the most critical phases in product development. This guide breaks down the key challenges, validation requirements, and strategies companies need to scale efficiently with the support of an experienced CMO.
What Are the Biggest Sterilization Challenges for Complex Medical Devices, and How Can Manufacturers Solve Them?
As medical devices become smaller, more advanced, and increasingly complex, sterilization has emerged as one of the most critical challenges in manufacturing. Intricate geometries, mixed materials, and strict regulatory requirements make achieving consistent sterility without compromising performance a significant hurdle. This article explores the most common sterilization challenges manufacturers face and outlines practical strategies to ensure safety, compliance, and scalability from development through commercialization.
PiSA USA’s Marie O’Malley to Speak at The Future of Sterilization Workshop at MD&M West 2026
PiSA USA announced that Marie O’Malley, Chief Commercial Officer, will speak at The Future of Sterilization Workshop at MD&M West 2026 in Anaheim, California. The session will explore emerging sterilization technologies, regulatory considerations, and strategic implementation approaches for medical device and pharmaceutical manufacturers, highlighting PiSA USA and Centerpiece’s expertise in advanced sterilization, compliance, and supply chain solutions.
PISA-USA Pharma Injection Molding: What It Is, Key Requirements, and How High-Volume, High-Precision Manufacturing Works
Pharmaceutical injection molding is a high-precision process with zero margin for error. From material selection and cleanroom manufacturing to tooling, validation, and automated quality control, every detail impacts patient safety and regulatory compliance. In this article, PiSA-USA breaks down the fundamentals of pharma injection molding, outlines the critical requirements for regulated production, and explains how high-volume, high-precision manufacturing is achieved at scale—backed by decades of technical expertise and global manufacturing leadership.
Film & Tubing Extrusion in Medical Devices: Balancing Flexibility, Barrier Properties, Strength, and Biocompatibility
Film and tubing extrusion may seem like a small part of a medical device, but it directly impacts performance, safety, and long-term reliability. From IV sets to flexible solution bags, the materials and processes behind extrusion determine how well a device withstands pressure, maintains sterility, and interacts with the human body. At PiSA USA, extrusion is more than just a capability — it’s a core part of our vertically integrated manufacturing ecosystem, allowing us to deliver precise, compliant, and fully traceable components within complete end-to-end device assemblies.
ETO vs. Irradiation, Autoclave, and Emerging Sterilization Methods: Choosing the Right Approach for Your Medical Device
Selecting the right sterilization method is one of the most critical decisions in medical device manufacturing. From ETO to irradiation, autoclave, and emerging modalities like chlorine dioxide and X-ray, each technology offers unique advantages and limitations. This article explores how ethylene oxide (ETO) continues to set the standard for complex and heat-sensitive devices—while comparing it to other leading sterilization methods in terms of compatibility, efficiency, and scalability.
PiSA USA’s Marie O’Malley to Join MassMEDIC Fireside Chat on Technology Challenges in MedTech
PiSA USA is excited to share that Marie O’Malley, Vice President of Commercial Operations, will be a featured speaker at MEDevice Boston 2025. O’Malley will join MassMEDIC’s Fireside Chat: Breaking Barriers — Leading Through Technology Challenges in MedTech on October 1, 2025, bringing nearly 30 years of industry expertise to the stage. Known for her leadership in innovation, supply chain, and regulatory compliance, O’Malley will discuss how collaboration and forward-thinking strategies can turn technology challenges into opportunities for safer, more sustainable solutions.